Interleukin-6 and the hypothalamic-pituitary-adrenal activation in a tumor bearing mouse

International Journal of Neuroscience

Volumn 118, Issue 3, 2008, Pages 355-364

  Lee, Jong Ho ^a   Yoo, Sang Bae ^a   Kim, Nam Youl ^a   Cha, Mi Joo ^a   Jahng, Jeong Won ^a  

^a School of Dentistry   (South Korea)

Author keywords

Corticosterone; Cytokine; Gene expression; Human squamous cell carcinoma; Hypothalamus; Plasma

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CYTOKINE PRODUCTION; GENE EXPRESSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOUSE; MOUTH CARCINOMA; NONHUMAN; PHENOTYPE; SQUAMOUS CELL CARCINOMA; THALAMUS MIDLINE NUCLEUS;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANOREXIA; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERLEUKIN-6; LYMPHOCYTE SUBSETS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICE; MICE, INBRED BALB C; PITUITARY-ADRENAL SYSTEM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40049083988     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207450701592915     Document Type: Article

References (43)

1. Alesci, S., Martinez, P. E., Kelkar, S., Ilias, I., Ronsaville, D. S., Listwak, S. J., Ayala, A. R., Licinio, J., Gold, H. K., Kling, M. A., Chrousos, G. P., & Gold, P. W. (2005). Major depression is associated with significant diurnal elevations in plasma IL-6 levels, a shift of its circadian rhythm, and loss of physiologic complexity in its secretion: Clinical implications. Journal of Clinical Endocrinology & Metabolism, 90(5), 2522-2530.
2. Berkenbosch, F., van Oers, J., del Rey, A., Tilders, F., & Besedovsky, H. (1987). Corticotropin-releasing factor producing neurons in the rat activated by interleukin-1. Science, 238, 524-526.
3. Bernardini, R., Kamilaris, T. C., Calogero, A. E., Johnson, E. O., Gomez, M. T., Gold, P. W., & Chrousos, G. P. (1990). Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. Endocrinology, 126, 2876-2881.
4. Chance, W. T., Balasubramaniam, A., Dayal, R., Brown, J., & Fischer, J. E. (1994). Hypothalamic concentration and release of neuropeptide Y into microdialysates is reduced in anorectic tumor-bearing rats. Life Science, 54, 1869-1874.
5. Chance, W. T., Balasubramaniam, A., & Fischer, J. E. (1995). Neuropeptide Y and the development of cancer anorexia. Annals of Surgery, 221, 579-587.
6. Chrousos, G. P. (2000). Stress, chronic inflammation, and emotional and physical well-being: Concurrent effects and chronic sequelae. Journal of Allergy & Clinical Immunology, 106, S275-S291.
7. Collin, M., Hakansson-Ovesjo, M.-L., Misane, I., Ogren, S. O., & Meister, B. (2000). Decreased 5-HT transporter mRNA in neurons of the dorsal raphe nucleus and behavioral depression in the obese leptin-deficient ob/ob mouse. Molecular Brain Research, 81, 51-61.
8. del Rey, A., & Besedovsky, H. O. (1992). Metabolic and neuroendocrine effects of pro-inflamatory cytokines. European Journal of Clinical Investigation, 22(Suppl. 1), 10-15.
9. Goodwin, J. S., Zhang, D. D., & Ostir, G. V. (2004). Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. Journal of the American Geriatric Society, 52, 106-111.
10. Grignaschi, G., Sironi, F., & Samanin, R. (1996). Stimulation of 5-HT2A receptors in the paraventricular hypothalamus attenuates neuropeptide Y-induced hyperphagia through activation of corticotrophin releasing factor. Brain Research, 708, 173-176.
11. Haack, M., Hinze-Selch, D., Fenzel, T., Kraus, T., Kuhn, M., Schuld, A., & Pollmacher, T. (1999). Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis. Journal of Psychiatric Research, 33, 407-418.
12. Heinrichs, S. C., Menzaghi, F., Pich, E. M., Hauger, R. L., & Koob, G. F. (1993). Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Research, 611, 18-24.
13. Heinrichs, S. C., & Richard, D. (1999). The role of corticotrophin-releasing factor and urocortin in the modulation of ingestive behavior. Neuropeptides, 33, 350-359.
14. Holsboer, F., & Barden, N. (1996). Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine Reviews, 17, 187-205.
15. Hooghe-Peters, E., Velkeniers, B., Vanhaelst, L., & Hooghe, R. (1991). Interleukin-1, interleukin-6: Messengers in the neuroendocrine immune system? Pathology, Research and Practice, 87, 622-625.
16. Jahng, J. W., Houpt, T. A., Kim, S. J., Joh, T. H., & Son, J. H. (1998). Neuropeptide Y mRNA and serotonin innervation in the arcuate nucleus of anorexia mutant mice. Brain Research, 790, 67-73.
17. Jahng, J. W., Choi, S. H., Cha, M. J., Kim, N. Y., Hwang, S. J., & Lee, J. H. (2005). Serotonin transporter mRNA expression in the dorsal raphe nucleus of a tumor bearing mouse. Experimental & Molecular Medicine, 37, 72-76.
18. Johnson, E. O., Kamilaris, T. C., Chrousos, G. P., & Gold, P. W. (1992). Mechanisms of stress: A dynamic overviewof hormonal and behavioral homeostasis. Neuroscience & Biobehavioral Reviews, 16, 115-130.
19. Jones, T. H. (1994). Interleukin-6, an endocrine cytokine. Clinical Endocrinology, 40, 703-713.
20. Kaye, W. H. (1996). Neuropeptide abnormalities in anorexia nervosa. Psychiatry Research, 62, 65-74.
21. Kaye, W. H., Berrettini, W., Gwirtsman, H., & George, D. T. (1990). Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa. Archives of General Psychiatry, 47, 548-556.
22. Kelley, K. W., Bluthe, R. M., Dantzer, R., Zhou, J. H., Shen, W. H., Johnson, R. W., & Broussard, S. R. (2003). Cytokine-induced sickness behavior. Brain, Behavior, and Immunity, 17(Suppl. 1), S112-S118.
23. Klinkenberg, M., Willems, D. L., Wal, G., & Deeg, D. J. (2004). Symptom burden in the last week of life. Journal of Pain Symptom Manage, 27, 5-13.
24. Laviano, A., Meguid, M. M., & Rossi-Fanelli, F. (2003). Improving food intake in anorectic cancer patients. Current Opinion in Clinical Nutrition and Metabolic Care, 6, 421-426.
25. Lee, J. H., Cha, M. J., Choi, S. H., Hwang, S. J., Kim, D. G., & Jahng, J. W. (2004). Neuropeptide Y immunoreactivity and corticotropin-releasing hormone mRNA level are increased in the hypothalamus of mouse bearing a human oral squamous cell carcinoma. Neuropeptides, 38, 345-350.
26. Lira, A., Zhou, M., Castanon, N., Ansorge, M. S., Gordon, J. A., Francis, J. H., Bradley-Moore, M., Lira, J., Underwood, M. D., Arango, V., Kung, H. F., Hofer, M. A., Hen, R., & Gingrich, J. A. (2003). Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biological Psychiatry, 54, 960-971.
27. Lumpkin, M. D. (1987). The regulation of ACTH secretion by IL-1. Science, 238, 452-454.
28. Lyson, K., & McCann, S. M. (1991). The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology, 54, 262-266.
29. Maes, M. (1999). Major depression and activation of the inflammatory response system. Advances in Experimental Medicine and Biology, 461, 25-46.
30. Makrigiannakis, A., Margioris, A. N., Zoumakis, E., Stournaras, C., & Gravanis, A. (1999). The transcription of corticotropin-releasing hormone in human endometrial cells is regulated by cytokines. Neuroendocrinology, 70, 451-459.
31. Makarenko, I. G., Meguid, M. M., Gatto, L., Chen, C., & Ugrumov, M. V. (2003). Decreased NPY innervation of the hypothalamic nuclei in rats with cancer anorexia. Brain Research, 961, 100-108.
32. Matta, S. G., Weatherbee, J., & Sharp, B. M. (1992). A central mechanism in involved in the secretion of ACTH in response to IL-6 in rats: Comparison to and interaction with IL-1beta. Neuroendocrinology, 56, 516-525.
33. McCarthy, D. O., & Daun, J. M. (1993). The effects of cyclooxygenase inhibitors on tumor-induced anorexia in rats. Cancer, 71, 486-492.
34. McCarthy, H. D., McKibbin, P. E., Perkins, A. V., Linton, E. A., & Williams, G. (1993). Alterations in hypothalamic NPY and CRF in anorexic tumor bearing rats. American Journal of Physiology, 264, E638-643.
35. Menzaghi, F., Heinrichs, S. C., Pich, E. M., Tilders, F. J., & Koob, G. F. (1993). Functional impairment of hypothalamic corticotrophin-releasing factor neurons with immunotargeted toxins enhances food intake induced by neuropeptide Y. Brain Research, 681, 76-82.
36. Naitoh, Y., Fukata, J., Tominaga, T., Nakai, Y., Tamai, S., Mori, K., & Imura, H. (1988). Interleukin-6 stimulates the secretion of adrenocorticotrophic hormone in conscious, freely-moving rats. Biochemical and Biophysical Research Communications, 155, 1459-1463.
37. Richard, D., Lin, Q., & Timofeeva, E. (2002). The corticotrophin-releasing factor family of peptides and CRF receptors: Their roles in the regulation of energy balance. European Journal of Pharmacology, 440, 189-197.
38. Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., & Vale, W. (1987). Interleukin 1 stimulates the secretion of hypothalamic CRF. Science, 238, 522-524.
39. Spinedi, E., Hadid, R., Daneva, T., & Gaillard, R. C. (1992). Cytokines stimulate the CRH but not the vasopressin neuronal system: Evidence for a median eminence site of interleukin-6 action. Neuroendocrinology, 56, 46-53.
40. Turnbull, A. V., Pitossi, F. J., Lebrun, J.-J., Lee, S., Meltzer, J. C., Nance, D. M., del Rey, A., Besedovsky, H., & Rivier, C. (1997). Inhibition of tumor necrosis factor-alpha within the CNS markedly reduces the plasma adrenocorticotropin release to peripheral local inflammation in rats. Journal of Neuroscience, 17, 3262-3273.
41. Wang, J. P., & Dunn, A. J. (1998). Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochemistry International, 33, 143-154.
42. Wei, R., Phillips, T. M., & Sternberg, E. M. (2002). Specific up-regulation of CRH or AVP secretion by acetylcholine or lipopolysaccharide in inflammatory susceptible Lewis rat fetal hypothalamic cells. Journal of Neuroimmunology, 131, 31-40.
43. Zalcman, S., Green-Johnson, J. M., Murray, L., Nance, D. M., Dyck, D., Anisman, H., & Greenberg, A. H. (1994). Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Research, 643, 40-49.